2028年までのアジア太平洋脳腫瘍診断市場予測 - 診断タイプ別(画像検査、腰椎穿刺、生検、分子検査など)の新型コロナウイルス感染症の影響と地域分析。がんの種類(聴神経腫、星状細胞腫、頭蓋咽頭腫、神経節神経腫、多形膠芽腫、髄膜腫、上衣腫など);エンドユーザー (病院、専門クリニック、外来手術センターなど)

TIPRE00025896 | Pages: 159 | Medical Device | Nov 2021 | Type: Regional | Status: Published

市場紹介

脳がんは、腫瘍を引き起こす脳内の細胞の細胞外増殖によって引き起こされます。腫瘍には原発性脳腫瘍と続発性脳腫瘍が含まれます。原発性脳腫瘍は脳内で形成され、体の他の部分には広がりませんが、二次腫瘍(転移とも呼ばれます)は体の別の部分で発生したがんです。 脳腫瘍は 40 の主要なタイプに分類され、さらに 2 つの主要なグループに分類されます。1 つは良性、つまり成長が遅く転移する可能性が低いもの、悪性、つまり癌性で転移する可能性が高いものです。

< p>したがって、脳腫瘍の有病率の増加により、今後数年間で脳腫瘍診断に対する大きな需要が生み出されると予想され、それが脳腫瘍診断市場をさらに牽引すると予想されます。

今回の流行は深刻な影響を及ぼしています。アジア太平洋の医療観光産業に影響を及ぼし、サプライチェーンに混乱をもたらした。さらに、低所得国は、医療インフラの不足、病院がサプライヤーに課す制限、脳腫瘍診断装置の需要の減少などにより、さらなる課題に直面している。病気の伝播を防ぐために、韓国、マレーシア、シンガポール、フィリピン、インドでは制限措置が講じられています。これらの制限措置は、これらの国におけるサプライチェーンと医療機器の入手可能性に影響を与えることが予想されます。それは可処分所得に影響を与え、失業ももたらしました。さらに、完全なロックダウンの発動により、買収、合併、提携などの事業戦略が悪影響を受けます。事業活動におけるこのような障害は、脳腫瘍診断を含むさまざまな技術的に進んだ医療システムの導入を妨げると予測されています。

 

市場の概要とダイナミクス

アジア太平洋地域の脳腫瘍診断市場は、2021 年の 1 億 7,860 万米ドルから 1 億米ドルに成長すると予想されています2028年までに5億5,140万人。 2021 年から 2028 年にかけて 17.5% の CAGR で成長すると推定されています。「原発性脳腫瘍」という用語は、脳内で発生する腫瘍を指します。脳および神経系のがんは、男性および女性の死亡原因の第 10 位にあります。人の生涯において、この形態の腫瘍が発生する可能性は 1% 未満です。原発性中枢神経系 (CNS) 悪性腫瘍のほとんどは脳腫瘍であり、全症例の 85% ~ 90% を占めます。脳腫瘍は致命的となる可能性があり、生活の質に深刻な影響を及ぼし、最終的には患者とその家族の生活を一変させます。さらに、腫瘍の早期発見により、より多くの治療選択肢が得られることがよくあります。高度な画像技術により、脳腫瘍の位置を正確に特定できます。診断ツールには、磁気共鳴画像法 (MRI) およびコンピューター断層撮影 (CT または CAT スキャン) が含まれます。術中 MRI は、手術中の組織生検や腫瘍切除のガイドにも使用できます。磁気共鳴分光法 (MRS) は、腫瘍の化学的特徴を調べるために使用されます。したがって、脳腫瘍の有病率の増加により、脳腫瘍の診断ツールが強く求められています。      

 

主要市場セグメント

診断の種類に関しては、画像検査セグメントが2020年のアジア太平洋脳腫瘍診断市場で最大のシェアを占めました。癌の種類に関しては、多形神経膠芽腫セグメントが2020年のアジア太平洋脳腫瘍診断市場で最大のシェアを占めました。 2020。エンド ユーザーの観点から見ると、2020 年のアジア太平洋脳腫瘍診断市場では病院セグメントが最大のシェアを占めました。

 

リストされている主要な情報源と企業

脳腫瘍に関するこの報告書を作成するために参照されたいくつかの主要な一次および二次情報源アジア太平洋地域の診断市場には、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどが含まれます。このレポートに記載されている主要企業は、Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd.、Neusoft Medical Systems です。

 

理由レポートを購入する

  • アジア太平洋地域の脳腫瘍診断市場の状況を理解し、確実な評価を保証する可能性が最も高い市場セグメントを特定する。大きなリターン
  • アジア太平洋地域の脳がん診断市場における絶えず変化する競争環境を理解し、競争に先んじる
  • アジア太平洋地域の脳がん診断分野におけるM&Aおよび提携取引を効率的に計画する最も売上が見込める市場セグメントを特定することで市場を把握する
  • アジア太平洋脳腫瘍診断市場のさまざまなセグメントの市場パフォーマンスを知覚的かつ包括的に分析することで、知識に基づいたビジネス上の意思決定を行うのに役立ちます
  • 2021 年から 2028 年までのアジア太平洋地域におけるさまざまなセグメント別の市場収益予測。

 

アジア太平洋脳腫瘍診断市場セグメンテーション       

 

診断タイプ別

  • 画像検査
    • MRI
    • CT スキャン
    • PET
  • 生検
  • 分子検査
  • 腰椎穿刺
  • その他

 

がんの種類別

< ul>
  • 多形膠芽腫
  • 星状細胞腫
  • 上衣腫
  • その他
  •  

    作成者 エンド ユーザー

    • 病院
    • 専門クリニック
    • 外来手術センター
    • その他

     

    国別

    • アジア太平洋
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • アジア太平洋地域のその他の地域

     

    言及されている企業

    1. Thermo Fisher Scientific Inc.
    2. Siemens Healthineers A
    3. GE Healthcare
    4. Biocept, Inc .
    5. Koninklijke Philips NV
    6. キヤノン メディカル システムズ
    7. 日立製作所
    8. Neusoft Medical Systems

     

     

     

    TABLE OF CONTENTS

    1.           Introduction

    1.1          Scope of the Study

    1.2          The Insight Partners Research Report Guidance

    1.3          Market Segmentation

    1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

    1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

    1.3.3          Brain Cancer Diagnostics Market – By End User

    1.3.4          Asia Pacific Brain Cancer Diagnostics Market – By Country

    2.           Asia Pacific Brain Cancer Diagnostics Market – Key Takeaways

    3.           Research Methodology

    3.1          Coverage

    3.2          Secondary Research

    3.3          Primary Research

    4.           Asia Pacific Brain Cancer Diagnostics Market – Market Landscape

    4.1          Overview

    4.2          PEST Analysis

    4.2.1          Brain Cancer Diagnostics Market- Asia Pacific PEST Analysis

    4.3          Expert Opinion

    5.           Asia Pacific Brain Cancer Diagnostics Market - Key Market Dynamics

    5.1          Market Drivers

    5.1.1          Increase in Prevalence of Brain Cancer

    5.1.2          Rise in Number of Cigarette Smokers

    5.2          Market Restraints

    5.2.1          High Cost of Diagnosis

    5.3          Market Opportunities

    5.3.1          Increasing Opportunities in Emerging Economies

    5.4          Future Trends

    5.4.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

    5.5          Impact Analysis

    6.           Brain Cancer Diagnostics Market – Asia Pacific Analysis

    6.1          Asia Pacific Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

    7.           Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

    7.1          Overview

    7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

    7.3          Imaging Tests

    7.3.1          Overview

    7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.3          MRI

    7.3.3.1             Overview

    7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.4          CT Scan

    7.3.4.1             Overview

    7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.5          Positron emission tomography (PET)

    7.3.5.1             Overview

    7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.4          Lumbar Puncture

    7.4.1          Overview

    7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.5          Biopsy

    7.5.1          Overview

    7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.6          Molecular Testing

    7.6.1          Overview

    7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.7          Others

    7.7.1          Overview

    7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.           Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

    8.1          Overview

    8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

    8.3          Astrocytomas

    8.3.1          Overview

    8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.4          Glioblastoma Multiforme

    8.4.1          Overview

    8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.5          Ependymomas

    8.5.1          Overview

    8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.6          Others

    8.6.1          Overview

    8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.           Brain Cancer Diagnostics Market Analysis – By End user

    9.1          Overview

    9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

    9.3          Hospitals

    9.3.1          Overview

    9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.4          Specialty Clinics

    9.4.1          Overview

    9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.5          Ambulatory Surgical Centers

    9.5.1          Overview

    9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.6          Others

    9.6.1          Overview

    9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

    10.1        Asia Pacific: Brain Cancer Diagnostics Market

    10.1.1        Overview

    10.1.2        Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

    10.1.3        China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.3.1          China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.3.2          China: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.3.2.1           China: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

    10.1.3.3          China: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.3.4          China: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    10.1.4        Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.4.1          Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.4.2          Japan: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.4.2.1           Japan: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

    10.1.4.3          Japan: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.4.4          Japan: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    10.1.5        India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.5.1          India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.5.2          India: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.5.2.1           India: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

    10.1.5.3          India: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.5.4          India: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    10.1.6        Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1          Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2          Australia: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.6.2.1           Australia: Brain Cancer Diagnostics Market, By Imaging Tests, 2019–2028 (USD Million)

    10.1.6.3          Australia: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.6.4          Australia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    10.1.7        South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.7.1          South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.7.2          South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.7.2.1           South Korea: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

    10.1.7.3          South Korea: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.7.4          South Korea: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    10.1.8        Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.8.1          Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    10.1.8.2          Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

    10.1.8.2.1           Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

    10.1.8.3          Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

    10.1.8.4          Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

    11.        Impact Of COVID-19 Pandemic on Asia Pacific Brain Cancer Diagnostics Market

    11.1        Asia Pacific: Impact Assessment of COVID-19 Pandemic

    12.        Industry Landscape

    12.1        Overview

    12.2        Growth Strategies Done by the Companies in the Market, (%)

    12.1        Organic Developments

    12.1.1        Overview

    12.2        Inorganic Developments

    12.2.1        Overview

    13.        Company Profiles

    13.1        THERMO FISHER SCIENTIFIC INC.

    13.1.1        Key Facts

    13.1.2        Business Description

    13.1.3        Products and Services

    13.1.4        Financial Overview

    13.1.5        SWOT Analysis

    13.1.6        Key Developments

    13.2        Siemens Healthineers AG

    13.2.1        Key Facts

    13.2.2        Business Description

    13.2.3        Products and Services

    13.2.4        Financial Overview

    13.2.5        SWOT Analysis

    13.2.6        Key Developments

    13.3        GE Healthcare

    13.3.1        Key Facts

    13.3.2        Business Description

    13.3.3        Products and Services

    13.3.4        Financial Overview

    13.3.5        SWOT Analysis

    13.3.6        Key Developments

    13.4        Biocept, Inc.

    13.4.1        Key Facts

    13.4.2        Business Description

    13.4.3        Products and Services

    13.4.4        Financial Overview

    13.4.5        SWOT Analysis

    13.4.6        Key Developments

    13.5        Koninklijke Philips N.V.

    13.5.1        Key Facts

    13.5.2        Business Description

    13.5.3        Products and Services

    13.5.4        Financial Overview

    13.5.5        SWOT Analysis

    13.5.6        Key Developments

    13.6        Canon Medical Systems

    13.6.1        Key Facts

    13.6.2        Business Description

    13.6.3        Products and Services

    13.6.4        Financial Overview

    13.6.5        SWOT Analysis

    13.6.6        Key Developments

    13.7        Hitachi, Ltd.

    13.7.1        Key Facts

    13.7.2        Business Description

    13.7.3        Products and Services

    13.7.4        Financial Overview

    13.7.5        SWOT Analysis

    13.7.6        Key Developments

    13.8        Neusoft Medical Systems

    13.8.1        Key Facts

    13.8.2        Business Description

    13.8.3        Products and Services

    13.8.4        Financial Overview

    13.8.5        SWOT Analysis

    13.8.6        Key Developments

    14.        Appendix

    14.1        About the Insight Partners

    14.2        Glossary of Terms

     


    LIST OF TABLES

    Table 1.              China: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 2.              China: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 3.              China: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 4.              China: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 5.              Japan: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

    Table 6.              Japan: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

    Table 7.              Japan: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

    Table 8.              Japan: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 9.              India: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

    Table 10.            India: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

    Table 11.            India: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 12.            India: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 13.            Australia: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 14.            Australia: Brain Cancer Diagnostics Market, By Imaging Tests – Revenue and Forecast to 2028 (USD Million)

    Table 15.            Australia: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

    Table 16.            Australia: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 17.            South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 18.            South Korea: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 19.            South Korea: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 20.            South Korea: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 21.            Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 22.            Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 23.            Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 24.            Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 25.            Organic Developments in the Brain Cancer Diagnostics Market

    Table 26.            Inorganic Developments in the Brain Cancer Diagnostics Market

    Table 27.            Glossary of Terms, Brain Cancer Diagnostics Market

     


    LIST OF FIGURES

    Figure 1.            Brain Cancer Diagnostics Market Segmentation

    Figure 2.            Asia Pacific Brain Cancer Diagnostics Market Overview

    Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

    Figure 4.            India is Expected to Show Remarkable Growth During the Forecast Period

    Figure 5.            Brain Cancer Diagnostics Market - Asia Pacific PEST Analysis

    Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

    Figure 7.            Asia Pacific Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

    Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

    Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

    Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

    Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27.          Asia Pacific: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

    Figure 28.          Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 29.          China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 30.          Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 31.          India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 32.          Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 33.          South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 34.          Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 35.          Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 36.            Growth Strategies Done by the Companies in the Market, (%)
    1. Thermo Fisher Scientific Inc.
    2. Siemens Healthineers A
    3. GE Healthcare
    4. Biocept, Inc.
    5. Koninklijke Philips N.V
    6. Canon Medical Systems
    7. Hitachi, Ltd.
    8. Neusoft Medical Systems
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific brain cancer diagnostics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000